Literature DB >> 24999501

Extracellular and intracellular melanin in inflammatory middle ear disease.

Mark A Fritz, Pamela C Roehm, Michael A Bannan, Anil K Lalwani.   

Abstract

OBJECTIVES/HYPOTHESIS: Melanin is a pigmented polymer with a known role in dermal solar protection. In vertebrates, melanogenesis has been reported in leukocyte populations, suggesting a potential role in innate immunity. In this study, we report the novel finding of melanin associated with chronic inflammation and speculate on its potential role in the middle ear and mastoid. STUDY
DESIGN: Retrospective review of case series.
METHODS: Medical records of six patients who demonstrated melanin in the ear were reviewed.
RESULTS: Six patients from 1 to 63 years of age were identified with extracellular melanin and melanin-laden histiocytes within the middle ear and/or mastoid air cells at time of surgery. Concurrent intraoperative findings included cholesteatoma (n = 3), chronic suppurative otitis media (n = 2), and coalescent mastoiditis (n = 1). Histologically, extracellular melanin and melanin-laden histiocytes were identified by Fontana-Masson stain; absence of melanocytes was confirmed by the absence of Melan-A staining. One patient had a positive stain for CD163 (a marker for macrophages).
CONCLUSION: This case series is the first demonstration of melanin within middle ear mucosa without melanocytes in immediate proximity or metastatic melanocytic lesions. Melanin's presence in the setting of inflammation suggests that there may be a heretofore unreported link between the pigmentary and immune systems in the middle ear. LEVEL OF EVIDENCE: 4.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24999501      PMCID: PMC4513643          DOI: 10.1002/lary.24507

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  23 in total

1.  Melanoma of the middle ear: initial presentation, Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging and follow up.

Authors:  M W Huellner; M Cousin; T Linder; J D Soyka; C Bussmann; L Eberle; K Strobel
Journal:  J Laryngol Otol       Date:  2011-01-27       Impact factor: 1.469

Review 2.  The mole theory: primary function of melanocytes and melanin may be antimicrobial defense and immunomodulation (not solar protection).

Authors:  Craig G Burkhart; Craig N Burkhart
Journal:  Int J Dermatol       Date:  2005-04       Impact factor: 2.736

Review 3.  Extra-cutaneous melanin.

Authors:  A S Breathnach
Journal:  Pigment Cell Res       Date:  1988

4.  A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders.

Authors:  I C Le Poole; T Mutis; R M van den Wijngaard; W Westerhof; T Ottenhoff; R R de Vries; P K Das
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

5.  Results of an ultrastructural study comparing stria vascularis with organ of Corti in guinea pigs treated with kanamycin.

Authors:  B Gratacap; R Charachon; P Stoebner
Journal:  Acta Otolaryngol       Date:  1985 Mar-Apr       Impact factor: 1.494

6.  Round window niche melanocytes and webby tissue. Possible collateral route of vascular and perilymph circulation.

Authors:  R Gussen
Journal:  Arch Otolaryngol       Date:  1978-11

7.  Primary malignant melanoma of the middle ear mucosa: a case report.

Authors:  Ozmen Oztürk; Tekin Bağlam; Cüneyd Uneri; Sevgi Küllü
Journal:  Kulak Burun Bogaz Ihtis Derg       Date:  2006

8.  Anti-inflammatory and immunomodulating properties of grape melanin. Inhibitory effects on paw edema and adjuvant induced disease.

Authors:  N Avramidis; A Kourounakis; L Hadjipetrou; V Senchuk
Journal:  Arzneimittelforschung       Date:  1998-07

9.  Normal and metastatic melanin in the temporal bone.

Authors:  C M Navarrete; C B Ruah; P Schachern; M M Paparella
Journal:  Am J Otolaryngol       Date:  1995 Jan-Feb       Impact factor: 1.808

10.  Augmentation of intraocular inflammation by melanin.

Authors:  M Kaya; D P Edward; H Tessler; R L Hendricks
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.